Studies of HCV Infection, Vaccine Development and HCV-Host interactions
Studies of HCV Infection, Vaccine Development and HCV-Host interactions
批准号:
10697775
负责人:
T. Jake Liang
金额:
$56.91万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
3-DimensionalAnimal ModelAntibodiesBindingBiotinCell Culture SystemCellsClassificationComplexCryoelectron MicroscopyCrystallizationData SetDependenceDevelopmentDiazomethaneDimensionsDiseaseGene ExpressionGeneticGlycoproteinsHepatitis CHepatitis C TherapyHepatitis C VaccineHepatitis C virusIndividualInfectious hepatitidesIntegration Host FactorsLife Cycle StagesMediatingModelingMorbidity - disease rateNegative StainingPathogenesisPreventive vaccineProcessProteinsRNA InterferenceReceptor CellRecombinantsResolutionShapesStructural ModelsStructureTransmembrane DomainViralVirus DiseasesVirus ReplicationX-Ray Crystallographybasecrosslinkdensitydesignin vivomortalityneutralizing antibodyparticlesmall moleculestemtherapeutic targetthree-dimensional modelingvaccine developmentvirus host interaction
中文摘要
HCV对宿主机制的依赖既复杂又广泛。每一种宿主依赖性都是潜在的治疗靶点。先前的努力已经成功地发现了HCV复制的重要步骤,但病毒生命周期中的许多基本过程仍未被描述。使用基于rnai的遗传学和感染性HCV细胞培养系统,我们确定了许多以前未被识别的HCV感染所需的宿主因子。
英文摘要
HCV dependencies on the host machinery are both intricate and extensive. Each of these host dependencies is a potential therapeutic target. Previous efforts have been successful in discovering important steps in HCV replication, yet many fundamental processes in the viral life cycle remain uncharacterized. Using RNAi-based genetics and an infectious HCV cell culture system, we identified many previously unrecognized host factors required for productive HCV infection.
Despite the development of highly effective HCV treatments, an effective prophylactic vaccine is still lacking. HCV infection is mediated by its envelope glycoproteins E1 and E2 in the entry process with E2 binding to cell receptors and E1 mediating endosomal fusion. The structure of E1E2 has only been partially resolved by the X-ray crystallography of the core domain of E2 protein (E2c) and its complex with various neutralizing antibodies. Structural understanding of the E1E2 heterodimer in its native form can advance the design of candidates for HCV vaccine development. Here we analyze the structure of recombinant HCV E1E2 heterodimer with the aid of well-defined monoclonal anti-E1 and E2 antibodies as well as a small molecule chlorcyclizine-diazirine-biotin that can target and cross-link the putative E1 fusion domain. 3D models were generated after extensive 2D classification analysis with negative-stain single particles datasets. We modeled the available crystal structures of the E2c and Fabs into the 3D volumes of E1E2-Fab complexes based on the shape and dimension of the domain density. The E1E2 heterodimer exists in monomeric form and consists of a main globular body presumably depicting the E1 and E2 stem/transmembrane domain and a protruding structure representing the E2c based on anti-E2 Fab binding. At low resolution, model generated from negatively stained analysis reveals the unique binding and orientation of individual or double Fabs onto the E1 and E2 components of the complex. Cryo-electron microscopy (cryo-EM) of double Fab complexes resulting in a refined structural model of the E1E2 heterodimer is presented.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.
黑猩猩中的丙型肝炎病毒JFH-1菌株感染与低致病性和自适应突变的出现有关。
DOI:
10.1002/hep.22422
发表时间:
2008-09
期刊:
HEPATOLOGY
影响因子:
13.5
作者:
[Kato, Takanobu, Choi, Youkyung, Elmowalid, Gamal, Sapp, Ronda K., Barth, Heidi, Furusaka, Akihiro, Mishiro, Shunji, Wakita, Takaji, Krawczynski, Krzysztof, Liang, T. Jake]
通讯作者:
Liang, T. Jake
DOI:
10.1038/s41467-017-01954-x
发表时间:
2017-11-27
期刊:
Nature communications
影响因子:
16.6
作者:
[Li Q, Lowey B, Sodroski C, Krishnamurthy S, Alao H, Cha H, Chiu S, El-Diwany R, Ghany MG, Liang TJ]
通讯作者:
Liang TJ
Erratum for Lowey et al., "Hepatitis C Virus Infection Induces Hepatic Expression of NF-κB-Inducing Kinase and Lipogenesis by Downregulating miR-122".
Lowey 等人的勘误表,“丙型肝炎病毒感染通过下调 miR-122 诱导 NF-κB 诱导激酶和脂肪生成的肝脏表达”。
DOI:
10.1128/mbio.02771-19
发表时间:
2019
期刊:
mBio
影响因子:
6.4
作者:
[Lowey,Brianna, Hertz,Laura, Chiu,Stephan, Valdez,Kristin, Li,Qisheng, Liang,TJake]
通讯作者:
Liang,TJake
Viral Hepatitis and Hepatocellular Carcinoma.
病毒性肝炎和肝细胞癌。
DOI:
10.1053/j.gastro.2018.12.016
发表时间:
2019
期刊:
Gastroenterology
影响因子:
29.4
作者:
[Liang,TJake, Terrault,Norah]
通讯作者:
Terrault,Norah
Hepatitis C Virus Infection Induces Hepatic Expression of NF-κB-Inducing Kinase and Lipogenesis by Downregulating miR-122.
丙型肝炎病毒感染通过下调 miR-122 诱导 NF-κB 诱导激酶和脂肪生成的肝脏表达。
DOI:
10.1128/mbio.01617-19
发表时间:
2019
期刊:
mBio
影响因子:
6.4
作者:
[Lowey,Brianna, Hertz,Laura, Chiu,Stephan, Valdez,Kristin, Li,Qisheng, Liang,TJake]
通讯作者:
Liang,TJake
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
-
批准号:7967807
-
项目类别:
-
资助金额:$48.34万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Studies of HCV Infection And HCV-Host interactions
-
批准号:8939616
-
项目类别:
-
资助金额:$88.38万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence
-
批准号:10697773
-
项目类别:
-
资助金额:$170.73万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence
-
批准号:7734190
-
项目类别:
-
资助金额:$46.61万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Molecular Approaches To Vaccine Development For Hepatitis C
-
批准号:7734192
-
项目类别:
-
资助金额:$50.67万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Nonalcoholic Steatohepatitis: Natural History and Therapy
-
批准号:7734346
-
项目类别:
-
资助金额:$46.61万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases
-
批准号:10248152
-
项目类别:
-
资助金额:$100.81万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Studies of HCV Infection And HCV-Host interactions
-
批准号:10000721
-
项目类别:
-
资助金额:$124.67万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases
-
批准号:10919437
-
项目类别:
-
资助金额:$219.81万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Mechanisms of Interferon Action and Resistance in Hepatitis C Virus Infection
-
批准号:7593665
-
项目类别:
-
资助金额:$50.13万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
-
批准号:8148938
-
项目类别:
-
资助金额:$38.98万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence
-
批准号:8553526
-
项目类别:
-
资助金额:$66.47万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Molecular Approaches To Vaccine Development For Hepatitis C
-
批准号:7967543
-
项目类别:
-
资助金额:$64.45万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Mechanisms of Interferon Action and Resistance in Hepatitis C Virus Infection
-
批准号:7734194
-
项目类别:
-
资助金额:$50.33万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence
-
批准号:8939614
-
项目类别:
-
资助金额:$70.7万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Molecular Approaches To Vaccine Development For Hepatitis C
-
批准号:7593663
-
项目类别:
-
资助金额:$49.8万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence
-
批准号:8148824
-
项目类别:
-
资助金额:$38.98万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
The Genetics of Disease Progression and Treatment Response in Hepatitis C
-
批准号:8148833
-
项目类别:
-
资助金额:$38.98万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Cell Culture And Animal Models of HCV Infection And HCV-Host interactions
-
批准号:8148826
-
项目类别:
-
资助金额:$51.97万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
Molecular Approaches To Vaccine Development For Hepatitis C
-
批准号:8148825
-
项目类别:
-
资助金额:$38.98万
-
财政年份:--
-
负责人:T. Jake Liang
-
依托单位:
海外基金